FibroBiologics, Inc. Common Stock (NASDAQ: FBLG) last traded at $1.44, up 11.63% on the session. The quote above updates while this page is open; the figures below are drawn from FibroBiologics, Inc. Common Stock’s own filings and are restated only when a new one is published.
FibroBiologics, Inc. Common Stock trades on NASDAQ under the ticker FBLG. Its market capitalisation is $9.59 million.
Valuation measures for FibroBiologics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $9.59M |
|---|---|
| Enterprise value | $9.37M |
| P/E ratio | 0.53 |
| Price / book | 2.07 |
| Beta | 0.46 |
Trailing-twelve-month figures tagged in FibroBiologics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$18.14M |
|---|---|
| EPS (TTM) | $2.71 |
| Return on equity | -391.26% |
| Cash | $3.52M |
Range and volume for FBLG over the past 52 weeks.
| 52-week high | $12.80 |
|---|---|
| 52-week low | $0.620 |
| Volume | 568.1K |
| Average volume | 170.9K |
| Previous close | $1.29 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.